Valvular & structural heart disease

Clinical Characteristics and Outcomes of Patients Screened for Transcatheter Tricuspid Valve Replacement: The TriACT Registry

JACC Cardiovasc IntervPublished Multicentre observational study

Authors' conclusion

This first real-world report of TTVR screening demonstrated a high screening failure rate, mainly related to large tricuspid annular diameter. Patients undergoing TTVR had superior TR reduction and symptom alleviation compared with bailout tricuspid transcatheter edge-to-edge repair, at the cost of greater procedural complications.

Study context

Population
Patients with tricuspid regurgitation (TR) screened for transcatheter tricuspid valve replacement (TTVR) at 7 centres on a compassionate-use basisscreened
Participants
149 patients
Exposure
TTVR vs bailout tricuspid TEER after failed TTVR screening
Outcome
NYHA functional class and TR grade
Follow-up
30-day follow-up
Methodological details7 centres, compassionate use
  • 7 centres
  • Compassionate use

Main finding

As reported in the abstract

NYHA class I or II (baseline to 30 days) and TR ≤1+ at 30 days
GroupNYHA I or IITR ≤1+
TTVRfrom 21% to 68%; P < 0.00197% (P < 0.001 from baseline)
Bailout TEERfrom 27% to 58%; P < 0.00143% (P < 0.001 from baseline)

NYHA I or II

TTVRfrom 21% to 68%; P < 0.001
Bailout TEERfrom 27% to 58%; P < 0.001

TR ≤1+

TTVR97% (P < 0.001 from baseline)
Bailout TEER43% (P < 0.001 from baseline)

Observational data: associations, not effects.

Secondary outcomes

TTVR screening failure rate

Screening failure rate, mainly large tricuspid annular diameter
74%

Technical success

Technical success
91%

All-cause mortality · 30 days

Mortality
8%

HF hospitalization · 30 days

HF hospitalization
5%

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Clinical Characteristics and Outcomes of Patients Screened for Transcatheter Tricuspid Valve Replacement: The TriACT Registry. JACC Cardiovasc Interv. Published 26 February 2024. doi:10.1016/j.jcin.2023.12.016

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.